Pharma News, 2015

Roche will help Upsher-Smith Laboratories co-develop its Phase II oral small molecule inhibitor of Vascular Adhesion Protein 1 (VAP-1) for inflammatory disease, the companies said today, throu...

Janssen Biotech and Janssen-Cilag International (Janssen) have submitted two applications in the US and Europe for approval of Stelara (ustekinumab) to treat adults with moderately to ...

PRINCETON, N.

RedHill Biopharma has completed the last dosing and scheduled follow-up patient visit ahead of top-line interim analysis in the Phase IIa proof-of-concept clinical study evaluating RHB-104 in patients...

A new study finds that a component of aspirin binds to an enzyme called GAPDH, which is believed to play a major role in neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntingt...

The world's first anti-ageing drug will be tested on humans next year in trials which could result in people being able to live healthily well into their 120s.

NEW YORK, NY, USA I November 25, 2015 I Pfizer Inc.

Shares in Dr Reddy's Lab, India's second biggest drugmaker, crashed 10 per cent on Thursday after the US drug regulator warned the company about a possible import ban from three of its units u...

Merck KGaA is considering a sale of its allergy business as the German company seeks to reduce debt following the $17 billion takeover of Sigma-Aldrich Corp.

Nov 27 - Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglome...

Federal regulators have signed off on a new type of flu vaccine with a booster in it, with the hope of better protecting seniors from the virus.

The main endpoint was the CR/CRh* rate within two cycles of BLINCYTO.